Literature DB >> 10112297

The relation between quantity and quality with coronary artery bypass graft (CABG) surgery.

D Banta1, M Bos.   

Abstract

Many technical procedures may be done with better quality at higher volumes. In this paper, we examine the experience with coronary artery bypass graft (CABG) surgery. Immediate death rates (death during the hospital admission) with CABG vary widely, from lows of 1 percent or so to highs approaching 15 percent and perhaps higher. Research from the United States demonstrates clearly that there is a volume effect. Centres and surgeons with higher volumes have lower immediate mortality. The volume effect persists even at relatively high levels, that is, above 650 procedures a year for a hospital and above 116 procedures a year for a physician. This fact strongly supports regulation to centralize CABG facilities. In The Netherlands and Sweden, CABG is so regulated. No other European countries have strong regulation to centralize CABG provisions. Outcomes could be improved by such regulation.

Entities:  

Mesh:

Year:  1991        PMID: 10112297     DOI: 10.1016/0168-8510(91)90139-o

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  4 in total

1.  Hospital Surgical Volumes and Mortality after Coronary Artery Bypass Grafting: Using International Comparisons to Determine a Safe Threshold.

Authors:  Nils Gutacker; Karen Bloor; Richard Cookson; Chris P Gale; Alan Maynard; Domenico Pagano; José Pomar; Enrique Bernal-Delgado
Journal:  Health Serv Res       Date:  2016-05-16       Impact factor: 3.402

2.  Volume and outcome in coronary artery bypass graft surgery: true association or artefact?

Authors:  A J Sowden; J J Deeks; T A Sheldon
Journal:  BMJ       Date:  1995-07-15

Review 3.  Quality: link with effectiveness.

Authors:  T A Sheldon
Journal:  Qual Health Care       Date:  1994-06

4.  Hospital coronary artery bypass graft surgery volume and patient mortality, 1998-2000.

Authors:  Saif S Rathore; Andrew J Epstein; Kevin G M Volpp; Harlan M Krumholz
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.